ACTIVATION OF CASEIN KINASE-II IN ML-1 HUMAN MYELOBLASTIC-LEUKEMIA CELLS REQUIRES IGF-1 AND TRANSFERRIN

Citation
Lg. Wang et al., ACTIVATION OF CASEIN KINASE-II IN ML-1 HUMAN MYELOBLASTIC-LEUKEMIA CELLS REQUIRES IGF-1 AND TRANSFERRIN, Journal of leukocyte biology, 57(2), 1995, pp. 332-334
Citations number
14
Categorie Soggetti
Immunology,Hematology
ISSN journal
07415400
Volume
57
Issue
2
Year of publication
1995
Pages
332 - 334
Database
ISI
SICI code
0741-5400(1995)57:2<332:AOCKIM>2.0.ZU;2-N
Abstract
Casein kinase II (CK II), a key enzyme involved in the regulation of c ell growth, has been variously reported to be activated by diverse mit ogens, including insulin-like growth factor 1 (IGF-1) and epidermal gr owth factor (EGF). Activation of the enzyme is generally carried out i n the presence of serum, and we examined the question whether serum co mponents participate in the activation process. We demonstrated previo usly that ML-1 cells require IGF-1 plus transferrin (TF) for growth an d transforming growth factor beta or tumor necrosis factor alpha plus TF for differentiation. We now found that CK II is activated only when the cells are exposed to both IGF-1 and TF or when TF is replaced in this combination with relatively high levels of iron salts. Induction of differentiation with TGF-beta and TF did not result in CK II activa tion. These results show that CK II activation in ML-1 cells requires the application of both components of the growth signal, IGF-1 and TF, demonstrating that the growth factor alone is incapable of enhancing the activity of the enzyme.